London, UK, 07 June 2023: We are glad to announce that o2h Ventures has been nominated for EISA Awards as a finalist for the fourth time. Previously, we were finalists for Best Newcomer two years in a row (2020 & 2021) and in 2019, we were a finalist for an Outstanding Example Impactful EIS Investing. This time, we are honoured to be selected as a finalist in the esteemed EISA Impact Award category.
We at o2h Ventures have strongly believed in the power of life sciences innovation to improve human health and also contribute to the UK economy. Our focus has always been on early-stage investments in biotech companies specializing in pure-play discovery and therapeutics that can have profound impact on patients’ health in the long run.
Through our open human health Knowledge Intensive EIS and SEIS funds, we actively seek out companies developing assets for clinical trials and proof of concept and supporting companies having AI/ML and quantum computing to advance drug discovery.
The annual EISA Awards celebrate the outstanding achievements of members of the EIS and SEIS community. From entrepreneurs to investors, legal experts to financial advisors (and more), the community is a broad church.
To know more, click here.
About Enterprise Investment Scheme Association
The UK’s trade body for EIS and SEIS – the Enterprise Investment Scheme and Seed Enterprise Investment Scheme.
EISA is a highly effective not-for-profit organization which exists to aid the provision of capital to UK small and medium-sized enterprises (SMEs) through the Enterprise Investment Scheme (EIS) and the Seed Enterprise Investment Scheme (SEIS).
EISA works closely with HM Treasury, HM Revenue and Customs, Government Ministers, MPs and the FCA to enhance the EIS and promote the benefits of the scheme to investors and companies using EIS/SEIS and their respective advisers.
